![Jennifer K. Zimmons](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Jennifer K. Zimmons
Sociétés | Poste | Début | Fin |
---|---|---|---|
PROLUNG, INC. | Investor Relations Contact | - | - |
Historique de carrière de Jennifer K. Zimmons
Anciens postes connus de Jennifer K. Zimmons
Sociétés | Poste | Début | Fin |
---|---|---|---|
9 METERS BIOPHARMA, INC. | Investor Relations Contact | - | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Investor Relations Contact | 2 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
9 METERS BIOPHARMA, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
ProLung, Inc.
![]() ProLung, Inc. Medical SpecialtiesHealth Technology ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology, early stage lung cancer risk testing. It develops, tests and commercializes solutions which are designed to accelerate the time to diagnosis and expand the therapeutic window for lung cancer patients. Its product under the name of ProLung Test was developed to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography scan. The company was founded by Steven C. Eror on November 19, 2004 and is headquartered in Salt Lake City, UT. | Health Technology |
- Bourse
- Insiders
- Jennifer K. Zimmons
- Expérience